Company / Gross Profit per Share
Integra Lifesciences Holdings Gross Profit per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$10.13
FY2020
5-year range
-
FY2016-FY2020
Trend
-15.9%
vs FY2019
Sector context
#47 of 99
Health Care
What the data says
At $10.13, Integra Lifesciences Holdings's gross profit per share ranks #47 of 99 in the Health Care sector. Declined from $11.38 to $10.13 over the past 2 years.
Based on SEC 10-K filings.
10.13 in FY2020 with a 3-year CAGR of +4.0%.
Declined from $11.38 to $10.13 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#47 of 99 in Health CareTop 47% of 99This company $10.13 Sector average $13.98
▼
-27.5% below sector average
Key checks
Key Insights
- In FY2020, gross profit per share decreased 15.9% year-over-year.
- Ranks #47 out of 99 companies in the Health Care sector.
- Peak gross profit per share was recorded in FY2019.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $10.13 | -15.9% |
| FY2019 | $12.04 | +5.9% |
| FY2018 | $11.38 | +26.2% |
| FY2017 | $9.01 | +6.8% |
| FY2016 | $8.44 | -56.3% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026